{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:51:05Z","timestamp":1780361465853,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The study was sponsored by Pfizer Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0569-3","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T09:16:23Z","timestamp":1499159783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1841-0927","authenticated-orcid":false,"given":"Maurice","family":"Beghetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Rudzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"key":"569_CR1","unstructured":"Occurrence of Down syndrome. Centers for Disease Control and Prevention. 2014. Available at: http:\/\/www.cdc.gov\/ncbddd\/birthdefects\/downsyndrome\/data.html . Accessed 23 May 2017."},{"key":"569_CR2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00431-010-1200-0","volume":"169","author":"ME Weijerman","year":"2010","unstructured":"Weijerman ME, van Furth AM, van der Mooren MD, van Weissenbruch MM, Rammeloo L, Broers CJ, et al. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with down syndrome. Eur J Pediatr. 2010;169:1195\u20139.","journal-title":"Eur J Pediatr"},{"key":"569_CR3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00431-010-1378-1","volume":"170","author":"A Hawkins","year":"2011","unstructured":"Hawkins A, Langton-Hewer S, Henderson J, Tulloh RM. Management of pulmonary hypertension in down syndrome. Eur J Pediatr. 2011;170:915\u201321.","journal-title":"Eur J Pediatr"},{"key":"569_CR4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4250\/jcu.2015.23.2.72","volume":"23","author":"N Espinola-Zavaleta","year":"2015","unstructured":"Espinola-Zavaleta N, Soto ME, Romero-Gonzalez A, Gomez-Puente Ldel C, Munoz-Castellanos L, Gopal AS, et al. Prevalence of congenital heart disease and pulmonary hypertension in Down's syndrome: an Echocardiographic study. J Cardiovasc Ultrasound. 2015;23:72\u20137.","journal-title":"J Cardiovasc Ultrasound"},{"key":"569_CR5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1183\/09059180.00007910","volume":"19","author":"BJ Mulder","year":"2010","unstructured":"Mulder BJ. Changing demographics of pulmonary arterial hypertension in congenital heart disease. Eur Respir Rev. 2010;19:308\u201313.","journal-title":"Eur Respir Rev"},{"key":"569_CR6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/archotol.132.4.432","volume":"132","author":"SR Shott","year":"2006","unstructured":"Shott SR, Amin R, Chini B, Heubi C, Hotze S, Akers R. Obstructive sleep apnea: should all children with down syndrome be tested? Arch Otolaryngol Head Neck Surg. 2006;132:432\u20136.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"569_CR7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5664\/jcsm.27541","volume":"5","author":"MS Trois","year":"2009","unstructured":"Trois MS, Capone GT, Lutz JA, Melendres MC, Schwartz AR, Collop NA, et al. Obstructive sleep apnea in adults with down syndrome. J Clin Sleep Med. 2009;5:317\u201323.","journal-title":"J Clin Sleep Med"},{"key":"569_CR8","doi-asserted-by":"crossref","unstructured":"King P, Tulloh R. Management of pulmonary hypertension and down syndrome. Int J Clin Pract Suppl. 2011;174:8\u201313.","DOI":"10.1111\/j.1742-1241.2011.02823.x"},{"key":"569_CR9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00431-010-1361-x","volume":"170","author":"CL Cua","year":"2011","unstructured":"Cua CL, Rogers LK, Chicoine LG, Augustine M, Jin Y, Nash PL, et al. Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine. Eur J Pediatr. 2011;170:859\u201363.","journal-title":"Eur J Pediatr"},{"key":"569_CR10","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/ajmg.a.33555","volume":"152A","author":"H Fukushima","year":"2010","unstructured":"Fukushima H, Kosaki K, Sato R, Yagihashi T, Gatayama R, Kodo K, et al. Mechanisms underlying early development of pulmonary vascular obstructive disease in down syndrome: an imbalance in biosynthesis of thromboxane A2 and prostacyclin. Am J Med Genet A. 2010;152A:1919\u201324.","journal-title":"Am J Med Genet A"},{"key":"569_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/ped.12349","volume":"56","author":"T Saji","year":"2014","unstructured":"Saji T. Clinical characteristics of pulmonary arterial hypertension associated with down syndrome. Pediatr Int. 2014;56:297\u2013303.","journal-title":"Pediatr Int"},{"key":"569_CR12","doi-asserted-by":"crossref","unstructured":"McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573\u2013619.","DOI":"10.1016\/j.jacc.2009.01.004"},{"key":"569_CR13","first-page":"S3","volume":"34","author":"RJ Barst","year":"2009","unstructured":"Barst RJ, Richardson H, Konourina I. On behalf of the 1131 study group. Oral sildenafil treatment in children with pulmonary arterial hypertension (PAH): results of a double-blind, placebo-controlled, dose-ranging study [abstract #164]. Eur Resp J. 2009;34:S3\u20134.","journal-title":"Eur Resp J"},{"key":"569_CR14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.apmr.2009.02.015","volume":"90","author":"JC Vis","year":"2009","unstructured":"Vis JC, Thoonsen H, Duffels MG, de Bruin-Bon RA, Huisman SA, van Dijk AP, et al. Six-minute walk test in patients with down syndrome: validity and reproducibility. Arch Phys Med Rehabil. 2009;90:1423\u20137.","journal-title":"Arch Phys Med Rehabil"},{"key":"569_CR15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.hlc.2010.07.005","volume":"19","author":"FD Kermeen","year":"2010","unstructured":"Kermeen FD, Franks C, O'Brien K, Seale H, Hall K, McNeil K, et al. Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21. Heart Lung Circ. 2010;19:595\u2013600.","journal-title":"Heart Lung Circ"},{"key":"569_CR16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2008.02.025","volume":"134","author":"MG Duffels","year":"2009","unstructured":"Duffels MG, Vis JC, van Loon RL, Berger RM, Hoendermis ES, van Dijk AP, et al. Down patients with Eisenmenger syndrome: is bosentan treatment an option? Int J Cardiol. 2009;134:378\u201383.","journal-title":"Int J Cardiol"},{"key":"569_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2261-13-74","volume":"13","author":"R Crepaz","year":"2013","unstructured":"Crepaz R, Romeo C, Montanaro D, De Santis S. Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease. BMC Cardiovasc Disord. 2013;13:74.","journal-title":"BMC Cardiovasc Disord"},{"key":"569_CR18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2009.01.021","volume":"103","author":"MG Duffels","year":"2009","unstructured":"Duffels MG, Vis JC, van Loon RL, Nieuwkerk PT, van Dijk AP, Hoendermis ES, et al. Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down's syndrome. Am J Cardiol. 2009;103:1309\u201315.","journal-title":"Am J Cardiol"},{"key":"569_CR19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1460-9592.2009.02936.x","volume":"19","author":"N Eipe","year":"2009","unstructured":"Eipe N, Lai L, Doherty DR. Severe pulmonary hypertension and adenotonsillectomy in a child with Trisomy-21 and obstructive sleep apnea. Paediatr Anaesth. 2009;19:548\u20139.","journal-title":"Paediatr Anaesth"},{"key":"569_CR20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/sleep\/26.8.1006","volume":"26","author":"J Miguel-Diez de","year":"2003","unstructured":"de Miguel-Diez J, Villa-Asensi JR, Alvarez-Sala JL. Prevalence of sleep-disordered breathing in children with down syndrome: polygraphic findings in 108 children. Sleep. 2003;26:1006\u20139.","journal-title":"Sleep"},{"key":"569_CR21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1542\/peds.88.1.132","volume":"88","author":"CL Marcus","year":"1991","unstructured":"Marcus CL, Keens TG, Bautista DB, von Pechmann WS, Ward SL. Obstructive sleep apnea in children with down syndrome. Pediatrics. 1991;88:132\u20139.","journal-title":"Pediatrics"},{"key":"569_CR22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1164\/ajrccm.159.5.9809079","volume":"159","author":"S Redline","year":"1999","unstructured":"Redline S, Tishler PV, Schluchter M, Aylor J, Clark K, Graham G. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med. 1999;159:1527\u201332.","journal-title":"Am J Respir Crit Care Med"},{"key":"569_CR23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/adc.66.11.1333","volume":"66","author":"VA Stebbens","year":"1991","unstructured":"Stebbens VA, Dennis J, Samuels MP, Croft CB, Southall DP. Sleep related upper airway obstruction in a cohort with Down's syndrome. Arch Dis Child. 1991;66:1333\u20138.","journal-title":"Arch Dis Child"},{"key":"569_CR24","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/archinte.166.16.1763","volume":"166","author":"S Roizenblatt","year":"2006","unstructured":"Roizenblatt S, Guilleminault C, Poyares D, Cintra F, Kauati A, Tufik S. A double-blind, placebo-controlled, crossover study of sildenafil in obstructive sleep apnea. Arch Intern Med. 2006;166:1763\u20137.","journal-title":"Arch Intern Med"},{"key":"569_CR25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.amjcard.2004.04.047","volume":"94","author":"M Cappelli-Bigazzi","year":"2004","unstructured":"Cappelli-Bigazzi M, Santoro G, Battaglia C, Palladino MT, Carrozza M, Russo MG, et al. Endothelial cell function in patients with Down's syndrome. Am J Cardiol. 2004;94:392\u20135.","journal-title":"Am J Cardiol"},{"key":"569_CR26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00246-004-0767-5","volume":"26","author":"BC Cannon","year":"2005","unstructured":"Cannon BC, Feltes TF, Fraley JK, Grifka RG, Riddle EM, Kovalchin JP. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response. Pediatr Cardiol. 2005;26:565\u20139.","journal-title":"Pediatr Cardiol"},{"key":"569_CR27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","volume":"353","author":"N Werner","year":"2005","unstructured":"Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999\u20131007.","journal-title":"N Engl J Med"},{"key":"569_CR28","first-page":"40","volume":"3","author":"V Costa","year":"2010","unstructured":"Costa V, Sommese L, Casamassimi A, Colicchio R, Angelini C, Marchesano V, et al. Impairment of circulating endothelial progenitors in down syndrome. BMC Med Genet. 2010;3:40.","journal-title":"BMC Med Genet"},{"key":"569_CR29","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1161\/CIRCULATIONAHA.108.769646","volume":"117","author":"GP Diller","year":"2008","unstructured":"Diller GP, van Eijl S, Okonko DO, Howard LS, Ali O, Thum T, et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation. 2008;117:3020\u201330.","journal-title":"Circulation"},{"key":"569_CR30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-0033-1357757","volume":"25","author":"A Bialkowski","year":"2015","unstructured":"Bialkowski A, Moenkemeyer F, Patel N. Intravenous sildenafil in the management of pulmonary hypertension associated with congenital diaphragmatic hernia. Eur J Pediatr Surg. 2015;25:171\u20136.","journal-title":"Eur J Pediatr Surg"},{"key":"569_CR31","doi-asserted-by":"crossref","unstructured":"Bush D, Abman SH, Galambos C. Prominent intrapulmonary bronchopulmonary anastomoses and abnormal lung development in infants and children with Down Syndrome. J Pediatr. 2017;180:156\u201362.","DOI":"10.1016\/j.jpeds.2016.08.063"},{"key":"569_CR32","doi-asserted-by":"crossref","first-page":"e0159005","DOI":"10.1371\/journal.pone.0159005","volume":"11","author":"C Galambos","year":"2016","unstructured":"Galambos C, Minic AD, Bush D, et al. Increased lung expression of anti-angiogenic factors in down syndrome: potential role in abnormal lung vascular growth and the risk for pulmonary hypertension. PLoS One. 2016;11:e0159005.","journal-title":"PLoS One"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0569-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T12:16:14Z","timestamp":1659183374000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0569-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0569-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,4]]},"article-number":"177"}}